485828-75-9 Usage
General Description
1-(6-Chloropyridin-3-yl)cyclobutanecarbonitrile is a chemical compound with the molecular formula C10H8ClN. It is a cyclobutanecarbonitrile derivative that contains a chloropyridine group. 1-(6-Chloropyridin-3-yl)cyclobutanecarbonitrile is often used in the pharmaceutical industry as a building block for the synthesis of various drug molecules. It is known for its ability to participate in a variety of chemical reactions, making it a versatile intermediate in organic synthesis. The presence of the chloropyridine group in its structure makes it a valuable tool in medicinal chemistry, as it can be used to create novel compounds with potential biological activity. Overall, 1-(6-Chloropyridin-3-yl)cyclobutanecarbonitrile is an important chemical for drug discovery and development.
Check Digit Verification of cas no
The CAS Registry Mumber 485828-75-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,8,5,8,2 and 8 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 485828-75:
(8*4)+(7*8)+(6*5)+(5*8)+(4*2)+(3*8)+(2*7)+(1*5)=209
209 % 10 = 9
So 485828-75-9 is a valid CAS Registry Number.
485828-75-9Relevant articles and documents
NOVEL SALTS OF INDOLEAMINE 2,3-DIOXYGENASE INHIBITORS
-
Paragraph 0126, (2021/06/04)
Provided herein are compounds, salts, crystalline forms, and pharmaceutical compositions that are related to IDO inhibitors, in particular, Compound 1,1-(5-((4-chlorophenyl)amino)-6-(ethyl(tetrahydro-2H-pyran-4-yl)amino)pyridin-3-yl)cyclobutane-1-carboxylic acid. Also provided are methods of treating a disease or disorder such as a cancer or infectious disease that comprises administering to a subject in need thereof one or more of the compounds or compositions of the present disclosure.
INHIBITOR OF INDOLEAMINE-2,3-DIOXYGENASE (IDO)
-
Paragraph 00360-00361, (2017/09/05)
The present disclosure provides compounds of Formula (I). The compounds described herein may be useful in treating a disease associated with IDO, for example, cancer or an infectious disease (e.g., viral or bacterial infectious diseases). Also, provided in the present disclosure are pharmaceutical compositions, kits, methods, and uses including or using a compound described herein.
